These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 17936683)

  • 1. Development of a tripartite vector system for live oral immunization using a gram-negative probiotic carrier.
    Buddenborg C; Daudel D; Liebrecht S; Greune L; Humberg V; Schmidt MA
    Int J Med Microbiol; 2008 Jan; 298(1-2):105-14. PubMed ID: 17936683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delivery of heterologous protein antigens via hemolysin or autotransporter systems by an attenuated ler mutant of rabbit enteropathogenic Escherichia coli.
    Zhu C; Ruiz-Perez F; Yang Z; Mao Y; Hackethal VL; Greco KM; Choy W; Davis K; Butterton JR; Boedeker EC
    Vaccine; 2006 May; 24(18):3821-31. PubMed ID: 16098637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulation of mucosal immune response following oral administration of enterotoxigenic Escherichia coli fimbriae (CFA/I) entrapped in liposomes in conjunction with inactivated whole-cell Vibrio cholerae vaccine.
    Dima VF; Ionescu MD; Palade R; Balotescu C; Becheanu G; Dima SV
    Roum Arch Microbiol Immunol; 2001; 60(1):27-54. PubMed ID: 11850896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Split immune response after oral vaccination of mice with recombinant Escherichia coli Nissle 1917 expressing fimbrial adhesin K88.
    Remer KA; Bartrow M; Roeger B; Moll H; Sonnenborn U; Oelschlaeger TA
    Int J Med Microbiol; 2009 Nov; 299(7):467-78. PubMed ID: 19467927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral immunization of piglets with recombinant F4 fimbrial adhesin FaeG monomers induces a mucosal and systemic F4-specific immune response.
    Verdonck F; Cox E; Van der Stede Y; Goddeeris BM
    Vaccine; 2004 Oct; 22(31-32):4291-9. PubMed ID: 15474721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prime-boost vaccine regimen confers protective immunity to human-derived enterotoxigenic Escherichia coli.
    Lasaro MO; Luiz WB; Sbrogio-Almeida ME; Ferreira LC
    Vaccine; 2005 Mar; 23(19):2430-8. PubMed ID: 15752829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral immunization with attenuated Salmonella vaccine expressing Escherichia coli O157:H7 intimin gamma triggers both systemic and mucosal humoral immunity in mice.
    Oliveira AF; Cardoso SA; Almeida FB; de Oliveira LL; Pitondo-Silva A; Soares SG; Hanna ES
    Microbiol Immunol; 2012 Aug; 56(8):513-22. PubMed ID: 22671942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The polymeric stability of the Escherichia coli F4 (K88) fimbriae enhances its mucosal immunogenicity following oral immunization.
    Verdonck F; Joensuu JJ; Stuyven E; De Meyer J; Muilu M; Pirhonen M; Goddeeris BM; Mast J; Niklander-Teeri V; Cox E
    Vaccine; 2008 Oct; 26(45):5728-35. PubMed ID: 18762221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction of a non-toxigenic Escherichia coli oral vaccine strain expressing large amounts of CS6 and inducing strong intestinal and serum anti-CS6 antibody responses in mice.
    Tobias J; Svennerholm AM; Carlin NI; Lebens M; Holmgren J
    Vaccine; 2011 Nov; 29(48):8863-9. PubMed ID: 21983363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccination of attenuated EIS-producing Salmonella induces protective immunity against enterohemorrhagic Escherichia coli in mice.
    Gu J; Ning Y; Wang H; Xiao D; Tang B; Luo P; Cheng Y; Jiang M; Li N; Zou Q; Mao X
    Vaccine; 2011 Oct; 29(43):7395-403. PubMed ID: 21807051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction and phase I clinical evaluation of the safety and immunogenicity of a candidate enterotoxigenic Escherichia coli vaccine strain expressing colonization factor antigen CFA/I.
    Turner AK; Beavis JC; Stephens JC; Greenwood J; Gewert C; Thomas N; Deary A; Casula G; Daley A; Kelly P; Randall R; Darsley MJ
    Infect Immun; 2006 Feb; 74(2):1062-71. PubMed ID: 16428753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucosal and systemic responses of immunogenic vaccines candidates against enteric Escherichia coli infections in ruminants: A review.
    Lawan A; Jesse FFA; Idris UH; Odhah MN; Arsalan M; Muhammad NA; Bhutto KR; Peter ID; Abraham GA; Wahid AH; Mohd-Azmi ML; Zamri-Saad M
    Microb Pathog; 2018 Apr; 117():175-183. PubMed ID: 29471137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody response in mice immunized by mucosal routes with formalin-inactivated enteropathogenic Escherichia coli (EPEC) strains.
    Drago-Serrano ME; Manjarréz Hernandez HA; Gavilanes Parra S; Sainz Espuñes Tdel R
    Rev Latinoam Microbiol; 2004; 46(1-2):17-23. PubMed ID: 17061522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levamisole synergizes experimental F4ac+ Escherichia coli oral vaccine in stimulating ileal Peyer's patch T cells in weaned pigs.
    Bozić F; Lacković G; Kovsca-Janjatović A; Smolec O; Valpotić I
    J Vet Pharmacol Ther; 2006 Jun; 29(3):199-204. PubMed ID: 16669864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of an attenuated strain oral vaccine candidate using a novel double selection platform in Escherichia coli.
    Liu W; Yuan C; Bao J; Guan W; Zhao Z; Li X; Tang J; Li D; Shi D
    Appl Microbiol Biotechnol; 2015 Jan; 99(2):855-67. PubMed ID: 25301580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rational design of Salmonella-based vaccination strategies.
    Spreng S; Dietrich G; Weidinger G
    Methods; 2006 Feb; 38(2):133-43. PubMed ID: 16414270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral immunization of mice with plant-derived fimbrial adhesin FaeG induces systemic and mucosal K88ad enterotoxigenic Escherichia coli-specific immune responses.
    Liang W; Huang Y; Yang X; Zhou Z; Pan A; Qian B; Huang C; Chen J; Zhang D
    FEMS Immunol Med Microbiol; 2006 Apr; 46(3):393-9. PubMed ID: 16553813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucosal immunization using recombinant plant-based oral vaccines.
    Streatfield SJ
    Methods; 2006 Feb; 38(2):150-7. PubMed ID: 16431131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative evaluation of a vaccine candidate expressing enterotoxigenic Escherichia coli (ETEC) adhesins for colibacillosis with a commercial vaccine using a pig model.
    Hur J; Lee JH
    Vaccine; 2012 Jun; 30(26):3829-33. PubMed ID: 22507658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intestinal immunity of Escherichia coli NISSLE 1917: a safe carrier for therapeutic molecules.
    Westendorf AM; Gunzer F; Deppenmeier S; Tapadar D; Hunger JK; Schmidt MA; Buer J; Bruder D
    FEMS Immunol Med Microbiol; 2005 Mar; 43(3):373-84. PubMed ID: 15708311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.